Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 18, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	77,901	61,675	72,114	25,858	31,121	75,754
Market Cap Growth	-14.47%	-14.47%	178.88%	-16.91%	-58.92%	162.55%
Enterprise Value	94,980	81,726	96,197	55,452	54,820	95,516
Last Close Price	844.70	669.00	327.77	119.44	144.65	351.37
PE Ratio	2.17	1.72	-	-	-	28.22
PS Ratio	1.71	1.35	1.78	0.70	1.01	2.29
PB Ratio	3.01	2.38	3.48	1.19	1.31	2.69
P/TBV Ratio	5.42	4.29	6.75	2.28	2.49	4.52
P/FCF Ratio	17.63	13.96	12.37	-	-	41.18
P/OCF Ratio	11.38	9.01	10.29	58.23	-	15.74
EV/Sales Ratio	2.08	1.79	2.38	1.50	1.79	2.88
EV/EBITDA Ratio	11.80	10.18	13.92	16.30	-	16.07
EV/EBIT Ratio	15.51	13.39	18.69	38.52	-	22.31
EV/FCF Ratio	21.49	18.50	16.50	-	-	51.92
Debt / Equity Ratio	0.73	0.73	1.22	1.39	1.27	0.83
Debt / EBITDA Ratio	2.34	2.34	3.46	8.10	-	3.81
Debt / FCF Ratio	4.25	4.25	4.32	-	-	12.77
Asset Turnover	0.77	0.77	0.65	0.54	0.44	0.50
Inventory Turnover	1.65	1.65	1.59	1.52	1.36	1.43
Quick Ratio	0.54	0.54	0.55	0.59	0.58	0.52
Current Ratio	1.20	1.20	1.03	1.09	0.99	1.03
Return on Equity (ROE)	17.58%	17.58%	-7.00%	-10.13%	-18.25%	9.01%
Return on Assets (ROA)	6.42%	6.42%	5.16%	1.32%	-2.12%	4.06%
Return on Capital (ROIC)	8.43%	8.43%	6.57%	1.70%	-2.81%	5.36%
Return on Capital Employed (ROCE)	17.70%	17.70%	17.40%	3.90%	-	10.00%
Earnings Yield	46.13%	58.26%	-0.98%	-7.84%	-14.79%	3.54%
FCF Yield	5.67%	7.17%	8.08%	-1.95%	-12.89%	2.43%
Dividend Yield	102.28%	0.60%	0.76%	1.26%	-	0.71%
Payout Ratio	0.64%	0.64%	-	-	-	6.67%
Buyback Yield / Dilution	-1.12%	-1.12%	-1.02%	-0.37%	-0.04%	-0.14%
Total Shareholder Return	96.68%	-0.52%	-0.26%	0.89%	-0.04%	0.57%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.